From STAT: Despite accusing the pharmaceutical industry of “getting away with murder” by charging high drug prices, President Trump is now giving drug companies more power to charge higher prices overseas. Their price monopolies are likely to be extended under a draft executive order promising greater intellectual property protection in trade agreements.
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.